It hasn’t been a great couple of years for Johnson & Johnson. Since 2009, “faulty manufacturing” caused J&J to “recall millions of bottles and packages of Tylenol, Benadryl, Motrin and other over-the-counter medicines,” NBC News reports. While that was happening, pharmacies were starting to push their own private labels.

It got so bad that this past winter, CVS didn’t even stock Tylenol at a number of its stores. That isn't all. The company is facing over 10,000 lawsuits regarding the alleged failure of its Depuy metal-on-metal hip transplants, and it just got done paying $181 million in settlements over off-label marketing of its antipsychotic drug, Risperdal, Ad Age notes.

As Mad Men’s Don Draper says, if you don’t like what people are saying, you change the conversation. So J&J is going all-in on a rebrand, putting up to $30 million into a play-to-the-heartstrings Band-Aid of a campaign called “For All You Love.”Continue reading...

AB InBev is warned by U.K. regulators about ad linking Budweiser to "sexual success"; emerges as main suitor for maker of Presidente beer.

Apple and five book publishers are sued by Justice Department over e-book pricing, elevating role of Amazon in setting prices.

BrightSource Energy withdraws IPO in a blow to green power.

Conde Nast furthers its push into Hollywood.

Dish Network names P&G vet as new CMO.

Dollar General expands presence nationwide.

Dollar Shave Club puts men in a lather.

Dos Equis stalls marketing push because of recall of amber bottles. Continue reading...